Provided by Tiger Fintech (Singapore) Pte. Ltd.

uniQure NV

17.27
+0.66003.97%
Post-market: 16.90-0.3749-2.17%19:54 EDT
Volume:1.81M
Turnover:31.19M
Market Cap:945.51M
PE:-3.96
High:17.54
Open:16.95
Low:16.90
Close:16.61
Loading ...

uniQure files automatic mixed securities shelf

TIPRANKS
·
08 Jan

RBC Raises Price Target on uniQure to $24 From $20, Keeps Outperform, Speculative Risk

MT Newswires Live
·
07 Jan

Mizuho Securities Reaffirms Their Hold Rating on uniQure (QURE)

TIPRANKS
·
21 Dec 2024

uniQure call volume above normal and directionally bullish

TIPRANKS
·
20 Dec 2024

Uniqure Nv : Mizuho Raises Target Price to $20 From $7

THOMSON REUTERS
·
19 Dec 2024

uniQure price target raised to $32 from $12 at Stifel

TipRanks
·
17 Dec 2024

uniQure Is Maintained at Outperform by Leerink Partners

Dow Jones
·
12 Dec 2024

Stock Track | uniQure Soars 5.16% on FDA Alignment for Accelerated Approval Pathway of Huntington's Disease Gene Therapy

Stock Track
·
12 Dec 2024

QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug

Zacks
·
11 Dec 2024

Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More

Zacks
·
11 Dec 2024

RBC Raises Price Target on uniQure to $20 From $14, Keeps Outperform, Speculative Risk

MT Newswires Live
·
11 Dec 2024

uniQure price target raised to $44 from $26 at Leerink

TIPRANKS
·
11 Dec 2024

U.S. RESEARCH ROUNDUP-ICU Medical, Lennar Corp, Sweetgreen

Reuters
·
11 Dec 2024

Uniqure Nv : Leerink Partners Raises Target Price to $44 From $26

THOMSON REUTERS
·
11 Dec 2024

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live
·
11 Dec 2024

UniQure Gets Rating Upgrade From Wells Fargo After Agreement With FDA -- Shares Continue Rally

MT Newswires Live
·
11 Dec 2024

Wells Fargo Upgrades uniQure to Overweight From Equalweight, $35 Price Target

MT Newswires Live
·
11 Dec 2024

Wells upgrades uniQure on ‘high likelihood of success’ in Huntington’s

TIPRANKS
·
11 Dec 2024

uniQure Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Dec 2024

Stock Track | uniQure Soars 93.7% as FDA Agrees to Accelerated Approval Pathway for Huntington's Disease Gene Therapy

Stock Track
·
10 Dec 2024